DAFNA Capital Management’s Mereo BioPharma MREO Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-778,813	Closed	-$1.8M	–	78
2023 Q4	$1.8M	Sell	778,813 -183,700	-19%	-$424K	0.43%	45
2023 Q3	$1.24M	Sell	962,513 -46,500	-5%	-$60K	0.39%	49
2023 Q2	$1.33M	Sell	1,009,013 -87,500	-8%	-$116K	0.36%	47
2023 Q1	$775K	Hold	1,096,513	–	–	0.23%	52
2022 Q4	$822K	Hold	1,096,513	–	–	0.23%	55
2022 Q3	$944K	Hold	1,096,513	–	–	0.25%	59
2022 Q2	$1.23M	Sell	1,096,513 -120,100	-10%	-$135K	0.33%	58
2022 Q1	$1.36M	Buy	1,216,613 +90,000	+8%	+$101K	0.36%	63
2021 Q4	$1.8M	Hold	1,126,613	–	–	0.45%	47
2021 Q3	$2.73M	Hold	1,126,613	–	–	0.72%	38
2021 Q2	$3.57M	Sell	1,126,613 -123,035	-10%	-$390K	0.75%	35
2021 Q1	$4.21M	Buy	1,249,648 +581,500	+87%	+$1.96M	1%	29
2020 Q4	$2.39M	Buy	668,148 +468,723	+235%	+$1.68M	0.71%	36
2020 Q3	$522K	Buy	199,425 +122,625	+160%	+$321K	0.17%	73
2020 Q2	$235K	Buy	+76,800	New	+$235K	0.07%	83